As the U.S. cuts federal research funding and infrastructure, European countries are strategizing ways to attract top scientific talent, with the Netherlands government setting up a fund designed to do just that.
Fierce Biotech
信息服务
New York，New York 98,416 位关注者
The dominant B2B news brand for biotech. Delivering news, revealing insights straight to your inbox.
关于我们
Fierce Biotech is the dominant B2B news brand for the industry. Our focus daily is on biotech and medtech companies. We cover the drug and device development universe as well as the financing, deals, IPOs and M&A that happen along the way and the people who move biotech and medtech forward. Our coverage also feeds longer-form content, podcasts and events. Our journalists track the news closely and have developed a network of contacts to bring you exclusives. Our coverage runs the gamut from good news to bad and flattering to unflattering to give readers and listeners an unvarnished view of what’s truly happening. Delivering news, revealing insights straight to your inboxes: https://fiercebiotech.questexinfo.com/loading.do?omedasite=LS_full. Our family of publications includes Fierce Biotech, Fierce Biotech PM Tracker, Fierce Medtech, Fierce Biotech Research, Fierce CRO, Fierce Life Sciences Weekly Digest and Fierce Cell & Gene Therapy. Follow our podcast ‘The Top Line’ on Apple Podcasts, Spotify, Amazon, iHeart or wherever you get your podcasts. We dig into high-impact trends and recount the week’s biggest headlines. For Pharma news you can’t miss: https://www.dhirubhai.net/company/fierce-pharma For Healthcare news you can’t miss: https://www.dhirubhai.net/showcase/fierce-healthcare
- 网站
-
https://www.fiercebiotech.com/
Fierce Biotech的外部链接
- 所属行业
- 信息服务
- 规模
- 51-200 人
- 总部
- New York，New York
- 创立
- 2001
动态
-
Novo Nordisk is shaking up its early-stage R&D structure. I spoke to CSO Marcus Schindler about why this isn't simply a "cost-cutting exercise" or a knee-jerk reaction to the CagriSema data